These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 28540991

  • 1. Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis.
    Lee J, Park JH, Jwa H, Kim YH.
    Yonsei Med J; 2017 Jul; 58(4):778-785. PubMed ID: 28540991
    [Abstract] [Full Text] [Related]

  • 2. Comparing intravenous peramivir with oral oseltamivir for patients with influenza: a meta-analysis of randomized controlled trials.
    Fang YH, Hsu TH, Lin TY, Liu CH, Chou SC, Wu JY, Perng PC.
    Expert Rev Anti Infect Ther; 2021 Aug; 19(8):1039-1046. PubMed ID: 33641583
    [Abstract] [Full Text] [Related]

  • 3. Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection.
    Kohno S, Yen MY, Cheong HJ, Hirotsu N, Ishida T, Kadota J, Mizuguchi M, Kida H, Shimada J, S-021812 Clinical Study Group.
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5267-76. PubMed ID: 21825298
    [Abstract] [Full Text] [Related]

  • 4. A Meta-Analysis Comparing the Efficacy and Safety of Peramivir with Other Neuraminidase Inhibitors for Influenza Treatment.
    Chen JY, Wei SK, Lai CC, Weng TS, Wang HH.
    Medicina (Kaunas); 2020 Feb 05; 56(2):. PubMed ID: 32033501
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Peramivir: A Review in Uncomplicated Influenza.
    Scott LJ.
    Drugs; 2018 Sep 05; 78(13):1363-1370. PubMed ID: 30196350
    [Abstract] [Full Text] [Related]

  • 8. Clinical efficacy of peramivir in adult patients with seasonal influenza during the winter of 2012 in Japan.
    Yoshino Y, Seo K, Koga I, Kitazawa T, Ota Y.
    Clin Respir J; 2015 Apr 05; 9(2):228-32. PubMed ID: 24612842
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y, Saito R, Sato I, Kawashima T, Dapat C, Dapat IC, Kondo H, Suzuki Y, Saito K, Suzuki H.
    J Infect Chemother; 2012 Dec 05; 18(6):858-64. PubMed ID: 22644080
    [Abstract] [Full Text] [Related]

  • 13. Improvement of respiratory symptoms and health-related quality of life with peramivir in influenza patients with chronic respiratory disease: Additional outcomes of a randomized, open-label study.
    Kato M, Saisho Y, Tanaka H, Bando T.
    Influenza Other Respir Viruses; 2021 Sep 05; 15(5):651-660. PubMed ID: 33683019
    [Abstract] [Full Text] [Related]

  • 14. Post-marketing safety evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir: A drug-use investigation in patients with high risk factors.
    Komeda T, Ishii S, Itoh Y, Sanekata M, Yoshikawa T, Shimada J.
    J Infect Chemother; 2016 Oct 05; 22(10):677-84. PubMed ID: 27497712
    [Abstract] [Full Text] [Related]

  • 15. Absence of pharmacokinetic interaction between intravenous peramivir and oral oseltamivir or rimantadine in humans.
    Atiee G, Lasseter K, Baughman S, McCullough A, Collis P, Hollister A, Hernandez J.
    J Clin Pharmacol; 2012 Sep 05; 52(9):1410-9. PubMed ID: 21960669
    [Abstract] [Full Text] [Related]

  • 16. Clinical and virologic effects of four neuraminidase inhibitors in influenza A virus-infected children (aged 4-12 years): an open-label, randomized study in Japan.
    Hirotsu N, Saisho Y, Hasegawa T, Shishido T.
    Expert Rev Anti Infect Ther; 2018 Feb 05; 16(2):173-182. PubMed ID: 29284320
    [Abstract] [Full Text] [Related]

  • 17. Intravenous peramivir for treatment of influenza in hospitalized patients.
    Ison MG, Fraiz J, Heller B, Jauregui L, Mills G, O'Riordan W, O'Neil B, Playford EG, Rolf JD, Sada-Diaz E, Elder J, Collis P, Hernandez JE, Sheridan WP.
    Antivir Ther; 2014 Feb 05; 19(4):349-61. PubMed ID: 23985625
    [Abstract] [Full Text] [Related]

  • 18. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
    Onishi M, Kitano M, Taniguchi K, Homma T, Kobayashi M, Yoshinaga T, Naito A, Sato A.
    Antiviral Res; 2015 May 05; 117():52-9. PubMed ID: 25752738
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomised controlled trials.
    Gao Y, Guyatt G, Uyeki TM, Liu M, Chen Y, Zhao Y, Shen Y, Xu J, Zheng Q, Li Z, Zhao W, Luo S, Chen X, Tian J, Hao Q.
    Lancet; 2024 Aug 24; 404(10454):753-763. PubMed ID: 39181595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.